search results for: juno

French CAR-T biotech Mnemo Ther­a­peu­tics shut­ters US op­er­a­tions

Last year
People
Cell/Gene Tx

Pfiz­er, Bay­er lay off staff in Cal­i­for­nia; Mod­er­na signs gene edit­ing deal with David Hal­lal biotech

Last year
News Briefing

Eliem CEO ex­its as neu­ro up­start chops head­count, piv­ots to pre­clin­i­cal pro­gram

Last year
People
R&D

#JPM23 with Robert Nelsen: Our mot­to is 'do cool s@*t'

Last year

With the clin­ic in sight, Greg Verdine's start­up bags $178M for new class of tar­get­ed ther­a­pies

Last year
Financing
Startups

Bio­gen, Seagen lock in CEOs; 2022 so far — by the num­bers; Phar­ma on Twit­ter; Wave of biotech down­siz­ing ; and more

Last year
Weekly

Supreme Court toss­es Bris­tol My­er­s' bid to re­vive $1.2B CAR-T case against Gilead

Last year
Cell/Gene Tx
Law

Two Au­rinia ex­ecs are out — and CRISPR’s op­er­a­tions chief is­n't far be­hind; Bio­gen MS leader jumps to Eli Lil­ly ...

Last year
Peer Review

'Don't eat me' up­start taps Take­da vet on path to the clin­ic; Greg Mayes leaves An­tios for Cana­di­an psy­che­delics ...

Last year
Peer Review

The End­points 11: The top pri­vate biotechs in pur­suit of new drugs. Push­ing the en­ve­lope with pow­er­ful new ...

Last year
Special

Mod­er­na goes on the patent of­fen­sive; Pablo Legor­re­ta dou­bles down; Is a biotech re­cov­ery on the way?; and more

Last year
Weekly

Gilead fights back against BMS Supreme Court pe­ti­tion in patent fight

Last year
Pharma
Law

'Go quick­ly': Am­gen R&D vet Dirk Nagors­en jumps to a start­up with big plans for TCRs

Last year
People
R&D

Am­gen, GSK, Re­genxbio and oth­ers urge SCO­TUS to re­view 'dam­ag­ing' de­ci­sion on bio­med­ical patents

Last year
R&D
Law

Left be­hind at the Covid vac­cine start­ing line, Cure­Vac files suit against BioN­Tech over megablock­buster IP claims

Last year
Pharma
Law

Lat­est news on thumbs down for Nu­plazid; Amy­lyx’s first ALS ap­proval; Buy­out buzz for trou­bled biotechs; Cannes ...

Last year
Weekly

Bris­tol My­ers pe­ti­tions the Supreme Court in a fi­nal bid to prove Gilead­'s Kite in­fringed on CAR-T patents

Last year
Law

Time Pas­sages: Bruce Gold­smith out at Jim Wilson's gene ther­a­py biotech; Flag­ship re­veals Michael Sev­eri­no’s CEO ...

Last year
Peer Review
First page Previous page 12345 Next page Last page

latest

Most read

Ex­clu­sive: In $1B+ bet on AI, bio­phar­ma heavy­weights back new start­up to up­end drug R&D

12 hours ago
Startups
Deals

No­var­tis brings Lu­tathera to ado­les­cents with rare can­cer in first for ra­di­oli­gand class

3 hours ago
Pharma
FDA+

FDA gives ac­cel­er­at­ed ap­proval to Day One’s tar­get­ed treat­ment for most com­mon brain tu­mor in kids

4 hours ago
Pharma
FDA+

In­izio Evoke Comms taps Stephanie De­Vi­teri in re­turn to agency as pres­i­dent

5 hours ago
People
Marketing

Ver­tex li­cens­es TreeFrog’s tech to up­scale cell ther­a­py man­u­fac­tur­ing for di­a­betes can­di­dates

5 hours ago
Deals
Pharma
see latest stream
A service from the Financial Times